# Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects

> **NCT05829603** · PHASE1 · COMPLETED · sponsor: **Reconnect Labs** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Dimethyltryptamin (DMT) & Harmine

## Key facts

- **NCT ID:** NCT05829603
- **Lead sponsor:** Reconnect Labs
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-05
- **Primary completion:** 2023-09-17
- **Final completion:** 2023-10-17
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05829603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05829603, "Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05829603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*